Edelman Steven bought SENS once, on Nov 10, 2025
Director at Senseonics Holdings, Inc.
SEC CIK 0001683354 · Filings on SEC.gov ↗
Edelman Steven's record
3 months after each buy, from the first price a copier could get.
1 buy has 3 months of prices so far. A record shows here at 3.
Every filing
2 filings since May 2021, newest first
About Edelman Steven
Steven Edelman is an individual and a corporate insider serving as an independent director of Senseonics Holdings, Inc. (SENS), a medical technology company focused on long-term implantable continuous glucose monitoring systems for people with diabetes.( Senseonics reported that he joined its Board of Directors effective September 2, 2016, and recent insider filings show he received stock compensation in lieu of quarterly cash retainer fees.(
Edelman is a physician and endocrinologist who serves as a clinical professor of medicine in the Division of Endocrinology, Diabetes & Metabolism at the University of California San Diego and the Veterans Affairs Healthcare System of San Diego, where he also directs the Diabetes Care Clinic.( He is the founder and director of Taking Control of Your Diabetes (TCOYD), a nonprofit education organization, and his background includes medical training at UCLA, the University of California, Davis School of Medicine, the Joslin and Lahey Clinics, and a research fellowship at UC San Diego.(
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.